COVID-19 Impact on Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size, Status and Forecast 2020-2026

COVID-19 Impact on Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Age-Related Macular Degeneration (AMD) Therapeutics Revenue
1.4 Market Analysis by Type
1.4.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Wet AMD
1.4.3 Dry AMD
1.5 Market by Application
1.5.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Research Institute
1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): Age-Related Macular Degeneration (AMD) Therapeutics Industry Impact
1.6.1 How the Covid-19 is Affecting the Age-Related Macular Degeneration (AMD) Therapeutics Industry
1.6.1.1 Age-Related Macular Degeneration (AMD) Therapeutics Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Age-Related Macular Degeneration (AMD) Therapeutics Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Age-Related Macular Degeneration (AMD) Therapeutics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Age-Related Macular Degeneration (AMD) Therapeutics Market Perspective (2015-2026)
2.2 Age-Related Macular Degeneration (AMD) Therapeutics Growth Trends by Regions
2.2.1 Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Age-Related Macular Degeneration (AMD) Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Age-Related Macular Degeneration (AMD) Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Age-Related Macular Degeneration (AMD) Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Age-Related Macular Degeneration (AMD) Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Age-Related Macular Degeneration (AMD) Therapeutics Players by Market Size
3.1.1 Global Top Age-Related Macular Degeneration (AMD) Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Concentration Ratio
3.2.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Age-Related Macular Degeneration (AMD) Therapeutics Revenue in 2019
3.3 Age-Related Macular Degeneration (AMD) Therapeutics Key Players Head office and Area Served
3.4 Key Players Age-Related Macular Degeneration (AMD) Therapeutics Product Solution and Service
3.5 Date of Enter into Age-Related Macular Degeneration (AMD) Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Forecasted Market Size by Type (2021-2026)
5 Age-Related Macular Degeneration (AMD) Therapeutics Breakdown Data by Application (2015-2026)
5.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020)
5.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2015-2020)
6.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in North America (2019-2020)
6.3 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020)
6.4 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2015-2020)
7.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020)
7.4 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2015-2020)
8.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in China (2019-2020)
8.3 China Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020)
8.4 China Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2015-2020)
9.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020)
9.4 Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2015-2020)
10.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2015-2020)
11.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in India (2019-2020)
11.3 India Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020)
11.4 India Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2015-2020)
12.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Amgen Inc.
13.1.1 Amgen Inc. Company Details
13.1.2 Amgen Inc. Business Overview and Its Total Revenue
13.1.3 Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Introduction
13.1.4 Amgen Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020))
13.1.5 Amgen Inc. Recent Development
13.2 Bausch Health Companies, Inc.
13.2.1 Bausch Health Companies, Inc. Company Details
13.2.2 Bausch Health Companies, Inc. Business Overview and Its Total Revenue
13.2.3 Bausch Health Companies, Inc. Age-Related Macular Degeneration (AMD) Therapeutics Introduction
13.2.4 Bausch Health Companies, Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020)
13.2.5 Bausch Health Companies, Inc. Recent Development
13.3 F. Hoffmann-La Roche Ltd.
13.3.1 F. Hoffmann-La Roche Ltd. Company Details
13.3.2 F. Hoffmann-La Roche Ltd. Business Overview and Its Total Revenue
13.3.3 F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Introduction
13.3.4 F. Hoffmann-La Roche Ltd. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020)
13.3.5 F. Hoffmann-La Roche Ltd. Recent Development
13.4 Novartis AG
13.4.1 Novartis AG Company Details
13.4.2 Novartis AG Business Overview and Its Total Revenue
13.4.3 Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Introduction
13.4.4 Novartis AG Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020)
13.4.5 Novartis AG Recent Development
13.5 Regeneron Pharmaceuticals Inc.
13.5.1 Regeneron Pharmaceuticals Inc. Company Details
13.5.2 Regeneron Pharmaceuticals Inc. Business Overview and Its Total Revenue
13.5.3 Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Introduction
13.5.4 Regeneron Pharmaceuticals Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020)
13.5.5 Regeneron Pharmaceuticals Inc. Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Age-Related Macular Degeneration (AMD) Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Age-Related Macular Degeneration (AMD) Therapeutics Revenue
Table 3. Ranking of Global Top Age-Related Macular Degeneration (AMD) Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Wet AMD
Table 6. Key Players of Dry AMD
Table 7. COVID-19 Impact Global Market: (Four Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Age-Related Macular Degeneration (AMD) Therapeutics Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Age-Related Macular Degeneration (AMD) Therapeutics Players to Combat Covid-19 Impact
Table 12. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Regions (2015-2020)
Table 16. Global Age-Related Macular Degeneration (AMD) Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Age-Related Macular Degeneration (AMD) Therapeutics Market Growth Strategy
Table 22. Main Points Interviewed from Key Age-Related Macular Degeneration (AMD) Therapeutics Players
Table 23. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 24. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Players (2015-2020)
Table 25. Global Top Age-Related Macular Degeneration (AMD) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Age-Related Macular Degeneration (AMD) Therapeutics as of 2019)
Table 26. Global Age-Related Macular Degeneration (AMD) Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Age-Related Macular Degeneration (AMD) Therapeutics Product Solution and Service
Table 29. Date of Enter into Age-Related Macular Degeneration (AMD) Therapeutics Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 32. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Share by Type (2015-2020)
Table 33. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Type (2021-2026)
Table 34. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Share by Application (2015-2020)
Table 35. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 36. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Share by Application (2021-2026)
Table 37. North America Key Players Age-Related Macular Degeneration (AMD) Therapeutics Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Age-Related Macular Degeneration (AMD) Therapeutics Market Share (2019-2020)
Table 39. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 40. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2015-2020)
Table 41. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 42. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2015-2020)
Table 43. Europe Key Players Age-Related Macular Degeneration (AMD) Therapeutics Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Age-Related Macular Degeneration (AMD) Therapeutics Market Share (2019-2020)
Table 45. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2015-2020)
Table 47. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2015-2020)
Table 49. China Key Players Age-Related Macular Degeneration (AMD) Therapeutics Revenue (2019-2020) (Million US$)
Table 50. China Key Players Age-Related Macular Degeneration (AMD) Therapeutics Market Share (2019-2020)
Table 51. China Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 52. China Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2015-2020)
Table 53. China Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 54. China Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2015-2020)
Table 55. Japan Key Players Age-Related Macular Degeneration (AMD) Therapeutics Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Age-Related Macular Degeneration (AMD) Therapeutics Market Share (2019-2020)
Table 57. Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2015-2020)
Table 59. Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Age-Related Macular Degeneration (AMD) Therapeutics Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Age-Related Macular Degeneration (AMD) Therapeutics Market Share (2019-2020)
Table 63. Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2015-2020)
Table 65. Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2015-2020)
Table 67. India Key Players Age-Related Macular Degeneration (AMD) Therapeutics Revenue (2019-2020) (Million US$)
Table 68. India Key Players Age-Related Macular Degeneration (AMD) Therapeutics Market Share (2019-2020)
Table 69. India Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 70. India Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2015-2020)
Table 71. India Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 72. India Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Age-Related Macular Degeneration (AMD) Therapeutics Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Age-Related Macular Degeneration (AMD) Therapeutics Market Share (2019-2020)
Table 75. Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2015-2020)
Table 77. Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2015-2020)
Table 79. Amgen Inc. Company Details
Table 80. Amgen Inc. Business Overview
Table 81. Amgen Inc. Product
Table 82. Amgen Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020) (Million US$)
Table 83. Amgen Inc. Recent Development
Table 84. Bausch Health Companies, Inc. Company Details
Table 85. Bausch Health Companies, Inc. Business Overview
Table 86. Bausch Health Companies, Inc. Product
Table 87. Bausch Health Companies, Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020) (Million US$)
Table 88. Bausch Health Companies, Inc. Recent Development
Table 89. F. Hoffmann-La Roche Ltd. Company Details
Table 90. F. Hoffmann-La Roche Ltd. Business Overview
Table 91. F. Hoffmann-La Roche Ltd. Product
Table 92. F. Hoffmann-La Roche Ltd. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020) (Million US$)
Table 93. F. Hoffmann-La Roche Ltd. Recent Development
Table 94. Novartis AG Company Details
Table 95. Novartis AG Business Overview
Table 96. Novartis AG Product
Table 97. Novartis AG Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020) (Million US$)
Table 98. Novartis AG Recent Development
Table 99. Regeneron Pharmaceuticals Inc. Company Details
Table 100. Regeneron Pharmaceuticals Inc. Business Overview
Table 101. Regeneron Pharmaceuticals Inc. Product
Table 102. Regeneron Pharmaceuticals Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020) (Million US$)
Table 103. Regeneron Pharmaceuticals Inc. Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Wet AMD Features
Figure 3. Dry AMD Features
Figure 4. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Research Institute Case Studies
Figure 8. Other Case Studies
Figure 9. Age-Related Macular Degeneration (AMD) Therapeutics Report Years Considered
Figure 10. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Regions: 2020 VS 2026
Figure 12. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Players in 2019
Figure 15. Global Top Age-Related Macular Degeneration (AMD) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Age-Related Macular Degeneration (AMD) Therapeutics as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Age-Related Macular Degeneration (AMD) Therapeutics Revenue in 2019
Figure 17. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Amgen Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Amgen Inc. Revenue Growth Rate in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020)
Figure 26. Bausch Health Companies, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Bausch Health Companies, Inc. Revenue Growth Rate in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020)
Figure 28. F. Hoffmann-La Roche Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020)
Figure 30. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Novartis AG Revenue Growth Rate in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020)
Figure 32. Regeneron Pharmaceuticals Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Regeneron Pharmaceuticals Inc. Revenue Growth Rate in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020)
Figure 34. Bottom-up and Top-down Approaches for This Report
Figure 35. Data Triangulation
Figure 36. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs